In infants with hip dysplasia, no significant differences were detected in terms of IGF-1, IGF-BP3, and IGF-BP5 levels and the other categorical variables (sex, primigravida/multiparity data, DDH subtype and side). This evidence concerns the gene IGFBP3 and Hip dysplasia.